These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2966151)

  • 1. K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase.
    Nakanishi S; Yamada K; Kase H; Nakamura S; Nonomura Y
    J Biol Chem; 1988 May; 263(13):6215-9. PubMed ID: 2966151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
    Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets.
    Yamada K; Iwahashi K; Kase H
    Biochem Pharmacol; 1988 Mar; 37(6):1161-6. PubMed ID: 3128296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
    White JR; Zembryki D; Hanna N; Mong S
    Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin.
    Ohmori K; Ishii H; Manabe H; Satoh H; Tamura T; Kase H
    Arzneimittelforschung; 1988 Jun; 38(6):809-14. PubMed ID: 2972291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS; Kawai A
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action.
    Akinaga S; Ashizawa T; Gomi K; Ohno H; Morimoto M; Murakata C; Okabe M
    Cancer Chemother Pharmacol; 1992; 29(4):266-72. PubMed ID: 1537071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
    Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
    J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of chicken gizzard myosin light-chain kinase, and its calcium and strontium sensitivities as compared with those of superprecipitation and ATPase activities of actomyosin.
    Uchiwa H; Kato T; Onishi H; Isobe T; Okuyama T; Watanabe S
    J Biochem; 1982 Jan; 91(1):273-82. PubMed ID: 6461641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by amiloride of contractile elements in smooth muscle of guinea pig taenia cecum and chicken gizzard.
    Ozaki H; Kojima T; Moriyama T; Karaki H; Urakawa N; Kohama K; Nonomura Y
    J Pharmacol Exp Ther; 1987 Oct; 243(1):370-7. PubMed ID: 2822905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective binding of L-thyroxine by myosin light chain kinase.
    Hagiwara M; Mamiya S; Hidaka H
    J Biol Chem; 1989 Jan; 264(1):40-4. PubMed ID: 2909527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    Nakajima T; Katoh A
    Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
    Wang LH; Paden AJ; Johnson EM
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of inhibition of light-chain phosphorylation by purealin in chicken gizzard myosin.
    Takito J; Ohizumi Y; Nakamura H; Kobayashi J; Ebisawa K; Nonomura Y
    Eur J Pharmacol; 1987 Oct; 142(2):189-95. PubMed ID: 2961581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of gizzard myosin light chain and the ATPase reaction and superprecipitation of skeletal acto-gizzard myosin as functions of ATP concentration.
    Ohtsuka I; Kasai M; Kimura K; Onishi H; Watanabe S
    J Biochem; 1980 May; 87(5):1379-85. PubMed ID: 6446551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+-independent gizzard myosin light chain kinase produced by cross-linking of the enzyme with calmodulin using glutaraldehyde.
    Nakamura S; Nonomura Y
    J Biochem; 1986 May; 99(5):1359-69. PubMed ID: 2940235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin-linked equilibria in smooth muscle myosin light chain kinase.
    Malencik DA; Anderson SR
    Biochemistry; 1986 Feb; 25(3):709-21. PubMed ID: 3754154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
    Saitoh M; Ishikawa T; Matsushima S; Naka M; Hidaka H
    J Biol Chem; 1987 Jun; 262(16):7796-801. PubMed ID: 3108259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.